"Located in Los Angeles, Huntington Park, Panorama City, Santa Ana, and Gardena, National Research Institute has provided free quality medical and quality care to patients with Diabetes and Fatty Liver and has performed clinical trials for over 30 years."

During the past decade, Velocity Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Velocity Clinical Research" are "Mixed Dyslipidemia" (1 trials) and "NASH" (1 trials). Many other conditions were trialed in "Velocity Clinical Research" in a lesser frequency.

Most popular intervention types in "Velocity Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ARO-ANG3" (1 trials), "CSG452" (1 trials) and "K-877-ER" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velocity Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Velocity Clinical Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Velocity Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Velocity Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".